{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:38:23Z","timestamp":1762033103743},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.resinv.2012.12.002","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T16:51:30Z","timestamp":1361206290000},"page":"69-75","source":"Crossref","is-referenced-by-count":27,"title":["Effect of glucocorticoid monotherapy on pulmonary function and survival in Japanese patients with scleroderma-related interstitial lung disease"],"prefix":"10.1016","volume":"51","author":[{"given":"Katsutoshi","family":"Ando","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Motojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokuhide","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsutaro","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Aoshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2012.12.002_bib1","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/art.1780370903","article-title":"Severe restrictive lung disease in systemic sclerosis","volume":"37","author":"Steen","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2012.12.002_bib2","first-page":"2398","article-title":"Scleroderma patients with combined pulmonary hypertension and interstitial lung disease","volume":"30","author":"Chang","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.resinv.2012.12.002_bib3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/art.1780340405","article-title":"Predictors of survival in systemic sclerosis (scleroderma)","volume":"34","author":"Altman","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2012.12.002_bib4","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2012.12.002_bib5","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2012.12.002_bib6","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1002\/art.22204","article-title":"A multicenter, prospective, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma","volume":"54","author":"Holeys","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2012.12.002_bib7","first-page":"573","article-title":"Intravenous cyclophosphamide therapy for systemic sclerosis: a single-center experience and review of the literature with pooled analysis of lung function test results","volume":"22","author":"Airo","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.resinv.2012.12.002_bib8","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2012.12.002_bib9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s10067-004-0906-7","article-title":"Experience with azathioprine in systemic sclerosis associated with interstitial lung disease","volume":"23","author":"Dheda","year":"2004","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.resinv.2012.12.002_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00000478-200001000-00003","article-title":"Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia","volume":"24","author":"Travis","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.resinv.2012.12.002_bib11","unstructured":"The Japanese Respiratory Society. Nonspecific interstitial pneumonia (NSIP). Idiopathic interstitial pneumonias: diagnosis and treatment. 2nd ed. Nankodo; 2011. p. 74\u201382."},{"key":"10.1016\/j.resinv.2012.12.002_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.resinv.2012.12.002_bib13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1164\/rccm.200611-1696OC","article-title":"Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival","volume":"177","author":"Sumikawa","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2012.12.002_bib14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/rheumatology\/keh067","article-title":"Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis","volume":"43","author":"Mukerjee","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.resinv.2012.12.002_bib15","first-page":"421","article-title":"Reference values for lung function in the Japanese: recording of normal lung function from 11 institutes in Japan","volume":"31","author":"Sharp","year":"1993","journal-title":"Jpn J Thoracic Dis"},{"key":"10.1016\/j.resinv.2012.12.002_bib16","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1164\/rccm.200702-326OC","article-title":"Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease","volume":"176","author":"Tashkin","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2012.12.002_bib17","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1136\/ard.2007.069518","article-title":"Scleroderma Lung Study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis","volume":"66","author":"Clements","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2012.12.002_bib18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10067-005-1157-y","article-title":"A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis","volume":"25","author":"Nadashkevich","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.resinv.2012.12.002_bib19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/rheumatology\/40.4.406","article-title":"Renal vascular damage in Japanese patients with systemic sclerosis","volume":"40","author":"Nishijima","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.resinv.2012.12.002_bib20","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.10775","article-title":"Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement","volume":"48","author":"Steen","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2012.12.002_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/art.21538","article-title":"Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease","volume":"54","author":"Trad","year":"2006","journal-title":"Arthritis Rheum"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534512001165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534512001165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T16:31:54Z","timestamp":1539880314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534512001165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S2212534512001165"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2012.12.002","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}